Table 1 Number (proportion) of trials categorised as suspected marketing trials by journal following the consensus meeting
YES | MAYBE | NO | Total number of eligible trials (%) | |
|---|---|---|---|---|
Annals of Internal Medicine | 1 | 0 | 4 | 5 (3) |
The BMJ | 0 | 0 | 15 | 15 (8) |
JAMA | 1 | 1 | 18 | 20 (10) |
Lancet | 18 | 4 | 36 | 58 (30) |
NEJM | 21 | 9 | 62 | 92 (47) |
PLOS Medicine | 0 | 0 | 4 | 4 (2) |
Total | 41 (21) | 14 (7) | 139 (72) | 194 |